Drug Cos. See Path To Legal Off-Label Marketing
The drug industry is using a Second Circuit ruling that blocked the U.S. Food and Drug Administration from prosecuting a salesman for promoting a drug for off-label uses to push the...To view the full article, register now.
Already a subscriber? Click here to view full article